As House leadership seeks to quickly pass broad legislation that would bolster price transparency and oversight across the health care system, the Energy & Commerce Committee will meet Tuesday (Sept. 19) to discuss a slew of additional drug pricing policies and reforms for pharmacy benefit managers that weren’t tucked into the larger tri-committee package sent to the House floor. The House was slated to vote on the Lower Costs, More Transparency Act (H.R. 5378), which aims primarily to make the...